Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption.

[1]  M. McKenna.  The mast cell and bone. , 1985 .

[2]  J. Kanis,et al.  INTRAVENOUS CLODRONATE IN THE TREATMENT AND RETREATMENT OF PAGET'S DISEASE OF BONE , 1985, The Lancet.

[3]  J. Kanis,et al.  Treatment of malignant hypercalcaemia with clodronate. , 1985, British Journal of Cancer.

[4]  F. Preston,et al.  The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma , 1983, British journal of haematology.

[5]  C. Blomqvist,et al.  LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES , 1983, The Lancet.

[6]  J. Coindre,et al.  [Bone mastocytosis and osteomalacia. Apropos of a case with histodynamic analysis on non-decalcified bone]. , 1983, Annales de pathologie.

[7]  T. Thompson,et al.  Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex. , 1982, Journal of clinical pathology.

[8]  E. Vignon,et al.  Long term effects of dichloromethylene diphosphonate in Paget's disease of bone. , 1982, The Journal of clinical endocrinology and metabolism.

[9]  T. A. Webb,et al.  Systemic mast cell disease: A clinical and hematopathologic study of 26 cases , 1982, Cancer.

[10]  E. Vignon,et al.  Long-term effects of dichloromethylene diphosphonate (CI2MDP) on skeletal lesions in multiple myeloma. , 1982, Metabolic bone disease & related research.

[11]  S. Teitelbaum,et al.  Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients. , 1981, Human pathology.

[12]  R. Evans,et al.  Bone metabolism in systemic mastocytosis. A case report. , 1981, The Journal of bone and joint surgery. American volume.

[13]  V. Rosinus.  [Osteosclerosis associated with systemic mastocytosis]. , 1980, Schweizerische medizinische Wochenschrift.

[14]  F. Preston,et al.  EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASE , 1980, The Lancet.

[15]  E. Siris,et al.  Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. , 1980, The New England journal of medicine.

[16]  R. G. Henderson,et al.  Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses. , 1979, The Quarterly journal of medicine.

[17]  J. Carpenter,et al.  Mithramycin in the treatment of systemic mastocytosis. , 1975, Annals of internal medicine.

[18]  P. Kelly,et al.  The nature of the metabolic bone disorder in acromegaly. , 1972, The Journal of laboratory and clinical medicine.

[19]  C. Hirson.  Urticaria Pigmentosa with Disseminated Mastocytosis Controlled with Chlorambucil , 1965, Proceedings of the Royal Society of Medicine.

[20]  J. Ultmann,et al.  SYSTEMIC MAST CELL DISEASE. , 1963, Annals of internal medicine.

[21]  S. Udenfriend,et al.  A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.